Canadian Drug Companies

[Onthego]

HEB NR 04/05/06 3.31

HBSC and HEB Update the Investment Community in All-New Interviews With www.wallst.net


2006-04-05 07:00 ET - News Release

Also News Release (U-HBSC) HUMAN BIOSYSTEMS



NEW YORK, April 5 /PRNewswire/ -- On March 31, Harry Masuda, CEO of Human BioSystems, Inc. updated the investment community in an all-new interview with www.wallst.net . Interview highlights include detailed discussions on the following topics:

-- how the company's blood platelet and organ preservation technology
improves on current standards
-- how the company's technology could reduce healthcare costs
for patients
-- recently closed $3.3 million financing
-- trends in the market bolstering the company's prospects for growth
-- lack of competition
-- upcoming milestones for investors to watch for

To hear the interview in its entirety, and to read an in-depth report on the company, visit http://wallst.net/superstock/hbsc/hbsc.html

On March 24, Dr. William Carter, Chairman and CEO of Hemispherx Biopharma, Inc. updated the investment community in an all-new interview with www.wallst.net . Interview highlights include detailed discussions on the following topics:

-- reasons why the company's patented drug, Ampligen, is considered a
strong candidate for treating avian flu
-- "broad economic implications" of recent test results
-- when the company expects to see earnings from its influenza drugs
-- trends in the company's target markets, and why the company is
positioned to capitalize on these trends
-- competitive edge
-- intellectual property

To hear the interviews in their entirety, visit http://www.wallst.net , and click on "Interviews." Interviews require free registration, and can be accessed either by locating the respective company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews" page or by entering the respective company's ticker symbol in the Search Archive window at the bottom of the "Interviews" page.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO )

About WallSt.net

www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The website is a leading provider of financial news, media, tools and community-driven applications for investors. www.wallst.net offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies. We are expecting to receive two thousand two hundred fifty dollars from Human BioSystems, Inc. for media and advertising services. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp .

Contact:
Nick Iyer
Digital Wall Street, Inc.
1-800-4-WALL-ST

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, [e-mail]
WallStreet Direct, Inc.



CONTACT: Nick Iyer of Digital Wall Street, Inc., 1-800-4-WALL-ST



Web site: http://wallst.net/superstock/hbsc/hbsc.html/
http://www.wallst.net/disclaimer/disclaimer.asp/
http://www.wallst.net/